Addiction & Substance Use

Why do so many die as a consequence of addiction? Sadly-and in some cases disastrously-affected individuals are never offered alternative approaches after one option fails. More in this commentary.

What medications are FDA approved for alcohol dependence? Take the quiz and learn more.

Many barriers can prevent physicians who have a substance use disorder from obtaining the help they need. However, in many states, all is not lost for physicians who willingly participate in treatment. Here, signs, symptoms, and intervention steps.

Pathological gambling is a common psychiatric condition that can present with a variety of symptoms. Treatment recommendations available for pathological gamblers, as well as resources for patients and their families in this Tipsheet.

How prevalent is dependence on amphetamines, cocaine, opioids, and other illicit drugs across the world? What is the associated disease burden? Insights here.

Insurers appear to have plenty of leeway to continue-or even expand-the kind of anti-psychiatrist policies at the core of 2 lawsuits filed last year. Details here.

The mental health community was given some much needed relief when the Obama Administration implemented the final rule be put in place from the 2008 Mental Health Parity and Addiction Equity Act. The new mandate will ensure that most health plans cover mental health and addiction services in the same way they treat other medical issues.

This article provides an overview of research concerning referral strategies for patients with substance use disorder and co-occurring disorders in the emergency department.

One might expect that treating nicotine use would be a leading priority for physicians. The reality is that this is not the case. More in this expert commentary, with practical tips for clinicians.

Stopping smoking affects the metabolism of a number of drugs used in the management of mental illness. Here, a summary of the author's published study on whether e-cigarettes with nicotine were more effective for smoking cessation than nicotine patches.

Smoking is the leading cause of preventable morbidity and mortality in the US. The majority of smokers want to quit, but only a fraction achieve this annually. New evidence shows it is possible to teach patients to weaken the link between craving and smoking until they are able to ride out any craving–and consequently quit.

What percentage of patients with schizophrenia have a comorbid cannabis use disorder? Take the quiz and learn more.

Psychiatrists are urged to familiarize themselves with these new drugs and the typical presentations of patients who use them since implications of misdiagnosis can be far-reaching.

The challenges of identifying patients at risk for alcohol withdrawal have been found to be mitigated by the development of a Risk Stratification Questionnaire, now being adopted by the VA regionally throughout New England. More in this video.

The authors evaluate the effects of nicotine and cannabis on neurocognitive function in individuals with schizophrenia and review potential pharmacological treatment strategies.

Can drugs be categorized as good (eg, medicinal), bad (eg, recreational with deleterious side effects and addiction issues), or is there a middle ground? That was the underlying theme in a lecture at PsychCongress, “Perils and Promise of Psychoactive Drugs: A Focus on Harm Reduction Psychiatry.”

In this podcast, Dr Michael Miller, Director of the American Board of Addiction Medicine, discusses addiction medicine, including the new ASAM, patient placement criteria, and DSM-5 changes.

If you could talk to a clinician-in-training about how they can better help people suffering from addiction, what would you say? A Q&A between Arjune Rama, MD, and comic Marc Maron.

We avoid a basic aspect of human existence-namely, we are all a little lost and not knowing, and we had better accept this. In reminding our patients that the worst fate in life is not to suffer-but to suffer alone-we also remind ourselves.

Half of all mental health disorders occur by age 14. Early interventions may mitigate progression to more serious and persistent mental health concerns.

Here, a psychiatrist certified by the American Board of Addiction Medicine discusses new treatment criteria for addiction.

Both the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry have identified substance abuse as a top risk factor for suicide in youths.

For patients with hepatic disease, benzodiazepines that are conjugated and renally cleared (eg, lorazepam) should be used instead of those metabolized by the liver. Take the quiz and learn more.

In a new study, "as needed" use of an opioid antagonist for heightened alcohol craving appeared to reduce the number of heavy drinking days and total amount of alcohol consumed.

Calling all psychiatrists: we conducted a survey of your opinions about prescribing medical cannabis and invite you to view the results.

Impulse control disorders are common psychiatric conditions in which affected individuals typically report significant impairment in social and occupational functioning, and may incur legal and financial difficulties as well.

Are there differences in the neuroimaging of persons who just gamble and those who pathologically gamble?

A panel of experts at the APA Annual Meeting discussed how changes in DSM-5 may affect clinical practice. Highlights here.

A clinician’s notes and clinical records should document and defend treatment decisions, and are the best defense in court. Here: 3 key things every patient record should include.

Thinking about suicidal behavior as a diagnosable problem will help bridge the gap in how psychiatrists think about suicidality and how it is perceived by patients and their families.